Telix Pharmaceuticals announces shareholder meeting
Bitget2026/09/21 01:56- Telix Pharmaceuticals will hold an extraordinary general meeting in November 2026.
- Shareholders will vote on the proposed merger to acquire ITM Isotope Technologies Munich for upfront consideration of USD 1.65 billion.
- The deal includes payment of about USD 1.25 billion in Telix shares, assumption of USD 302 million net debt, closing adjustments.
- Meeting agenda also covers potential contingent consideration of up to USD 700 million tied to FDA approvals and ITM-11 sales milestones.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Abraxas Capital Faces Over $100 Million Unrealized Loss on $704 Million Perpetual Contract Position
ASBIS posts August revenue up 91% to USD 604 million, sets monthly record
The new Roadster, postponed for nine years, finally has a release date! Morningstar maintains Tesla (TSLA.US) target price at $450: Supercars are not the valuation logic, FSD, Robotaxi, and Optimus are.
Tesla has officially announced that the new generation Roadster will be unveiled on October 1. However, institutions generally believe that this is primarily a branding campaign and will have minimal impact on the company's valuation.
Market Chatter: Paramount, California Settlement Talks Include Penalty for Missing 30-Film Pledge
Crypto prices
More
